How the spread of breast cancer affects treatment with anti-cancer drugs
The role of breast cancer organ specific metastasis on the therapeutic impact of anti-cancer drugs
This study is looking at how the spread of breast cancer to different parts of the body, like the liver or lungs, affects how well chemotherapy works, with the aim of finding better, more personalized treatments for people with advanced breast cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas El Paso NIH-funded |
| Lab location | 1 site (El Paso, United States) |
| Project ID | NIH-10606518 on NIH RePORTER |
What this research studies
This research investigates how the location of breast cancer metastasis, such as in the liver, lungs, or brain, influences the effectiveness of chemotherapy drugs. By creating models of breast cancer that has spread to different organs, the researchers will test how these cancer cells respond to various anti-cancer agents. Additionally, the study will examine how the immune system may impact the spread of cancer and its response to treatment. The goal is to develop more personalized treatment strategies that improve survival rates for patients with late-stage breast cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are women diagnosed with late-stage breast cancer that has metastasized to organs such as the liver, lungs, or brain.
Not a fit: Patients with early-stage breast cancer or those whose cancer has not metastasized may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options tailored to the specific locations of breast cancer metastases, potentially improving patient survival rates.
How similar studies have performed: Previous research has indicated that the location of cancer metastasis can affect treatment outcomes, suggesting that this approach may yield valuable insights.
Where this research is happening
El Paso, United States
- University of Texas El Paso — El Paso, United States (Active)
Researchers
- Principal investigator: Francia, Giulio — University of Texas El Paso
- Study coordinator: Francia, Giulio
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.